#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	10412	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2654	939.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1581	1581	C	1356	C,A	1021,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18516	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	1100.5	0	.	n	.	0	T695C	SNP	695	695	T	1134	1134	C	1409	C,A,G	1012,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18516	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	1100.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1776	1776	A	1265	A,G	973,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18516	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	1100.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2410	2410	C	1219	C,T	930,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18516	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	1100.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2484	2484	A	1351	A	1013	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18516	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	1100.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3036	3036	C	1222	C,G,A	913,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1570	folP	852	852	100.0	folP.l15.c4.ctg.1	1670	226.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1109	1111	AGC	322;324;316	A,C,G;G;C	244,1,1;247;244	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3534	231.8	1	SNP	p	S91F	0	.	.	271	273	TCC	641	643	TCC	301;301;300	T;C;C,G	228;227;224,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3534	231.8	1	SNP	p	D95N	0	.	.	283	285	GAC	653	655	GAC	307;304;306	G,C;A;C	228,1;228;232	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3534	231.8	1	SNP	p	D95G	0	.	.	283	285	GAC	653	655	GAC	307;304;306	G,C;A;C	228,1;228;232	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1114	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1499	186.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	626	628	ACC	290;294;295	ACC,ACCC;C,A;C	227,1;226,1;232	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1114	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1499	186.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	641	643	CAC	293;293;294	C;A,C;C,T	227;227,1;230,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1114	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1499	186.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	824	826	CAC	275;275;275	C;A;C,A	220;218;218,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1114	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1499	186.3	1	SNP	p	G45D	0	.	.	133	135	GGC	644	646	GGC	295;295;295	G;G;C	231;233;233	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	900	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1445	154.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3256	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3235	243.0	1	SNP	p	D86N	0	.	.	256	258	GAC	718	720	GAC	344;338;340	G,T;A,T,C;C	264,1;251,1,1;261	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3256	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3235	243.0	1	SNP	p	S87I	0	.	.	259	261	AGT	721	723	AGT	339;339;342	A,G;G,T;T	253,1;259,1;263	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3256	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3235	243.0	1	SNP	p	S87R	0	.	.	259	261	AGT	721	723	AGT	339;339;342	A,G;G,T;T	253,1;259,1;263	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3256	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3235	243.0	1	SNP	p	S87W	0	.	.	259	261	AGT	721	723	AGT	339;339;342	A,G;G,T;T	253,1;259,1;263	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3256	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3235	243.0	1	SNP	p	S88P	0	.	.	262	264	TCC	724	726	TCC	343;343;339	T,G;C;C	260,1;261;261	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	283	2922	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3192	218.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1975	1977	GGC	259;258;259	G;G,A;C	212;208,1;203	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1329	1331	GCA	387;387;389	G;C;A	287;283;288	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1332	1334	ATC	396;395;395	A,G;T;C	289,1;291;295	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1344	1346	GTG	389;389;390	G;T,A;G,A	293;289,1;293,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1344	1346	GTG	389;389;390	G;T,A;G,A	293;289,1;293,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1848	1850	ACC	297;299;298	A,G,C;C;C	220,1,1;218;228	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1902	1904	GCG	255;254;254	G;C,G;G	202;184,2;190	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1902	1904	GCG	255;254;254	G;C,G;G	202;184,2;190	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2025	2027	GGC	236;239;239	G,T,C;G,T;C,T	190,1,1;191,2;190,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2034	2036	GGC	224;224;224	G,C;G,A;C,G	179,3;182,1;181,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2860	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2568	262.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2052	2054	CCG	227;226;225	C,G;C,G;G,A	173,3;175,1;176,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3730	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3362	254.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1478	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2117	174.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	728	728	C	175	C	142	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1182	1184	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1185	1187	AAT	5;5;5	A;A;T	5;5;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1197	1199	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1209	1211	GCA	4;4;4	G;C;A	4;4;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1232	1234	GTA	4;4;4	G;T;A	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	136	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1350	25.5	0	.	p	.	0	D238fs	FSHIFT	712	712	G	1244	1244	G	3	G	3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	596	598	GGA	283;283;283	G;G;A	217;213;214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	F135L	NONSYN	403	405	TTT	857	859	CTT	232;233;235	C;T;T,G	190;189;189,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	881	883	GGA	240;245;245	G,T;G;A,C	187,2;193;189,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	D171G	NONSYN	511	513	GAT	965	967	GGT	255;255;254	G;G,A;T,G	202;198,1;204,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1019	1021	AGC	258;259;258	A;G,T;C,A	193;193,1;198,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1085	1085	T	253	T	207	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	1	SNP	p	G120K	0	.	.	358	360	GGT	812	814	GGT	244;248;245	G;G;T,A,G	201;205;202,1,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	1	SNP	p	A121N	0	.	.	361	363	GCC	815	817	GCC	243;242;242	G,T;C,A;C,A	196,1;199,1;199,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1598	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1808	221.2	1	SNP	p	A121D	0	.	.	361	363	GCC	815	817	GCC	243;242;242	G,T;C,A;C,A	196,1;199,1;199,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	106	porB3	990	217	95.39	porB3.l15.c4.ctg.2	228	6.4	0	.	p	.	0	L253A	NONSYN	757	759	TTG	42	44	GCG	2;2;2	G;C;G	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	106	porB3	990	217	95.39	porB3.l15.c4.ctg.2	228	6.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	102	104	ACT	10;10;10	A;C;T	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	106	porB3	990	217	95.39	porB3.l15.c4.ctg.2	228	6.4	0	.	p	.	0	K278N	NONSYN	832	834	AAA	117	119	AAC	8;8;8	A;A;C	4;4;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	106	porB3	990	217	95.39	porB3.l15.c4.ctg.2	228	6.4	0	.	p	.	0	R279H	NONSYN	835	837	CGC	120	122	CAC	8;8;8	C;A;C	4;4;4	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	5668	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5141	271.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2138	2140	AAT	282;282;281	A;A;T,G,A	228;232;228,1,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	694	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1314	142.9	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	249;249;252	A;T;G,C	202;203;205,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
